샘플 요청 목록

 카트 문의
시장보고서
상품코드
1873661

세계의 무릎 신경 절제술 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

Knee Denervation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 무릎 신경 절제술 시장 규모는 2024년에 3억 5,400만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 20.3%로 확대되어 2031년까지 12억 5,300만 달러로 재조정될 전망입니다.

본 보고서는 최근 무릎 신경 절제술에 대한 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구성 등의 관점에서 종합적인 평가를 제공합니다.

무릎 신경 절제술은 퇴행성 무릎관절증이나 인공관절 치환술 후 지속되는 통증 등 만성적인 무릎 통증을 완화하기 위한 최소침습적 의료 시술입니다. 이 시술은 무릎에서 뇌로 통증 신호를 전달하는 감각 신경을 선택적으로 차단합니다. 이를 통해 운동 기능에 영향을 주지 않고 관절의 가동성을 유지할 수 있습니다.

골관절염(OA)은 활액관절에 많이 나타나는 퇴행성 질환으로 관절 연골의 퇴행, 관절 가장자리와 연골 하부의 골증식 등을 유발할 수 있습니다. 무릎 골관절염(KOA)은 사지 관절에서 가장 흔한 무릎 질환입니다. 국내 통계에 따르면 우리나라에서는 3% 이상이 OA를 앓고 있으며, 그 중 대부분이 KOA로 인한 것입니다. 우리나라가 고령화 사회로 접어들면서 인구의 KOA 발병률이 높아지고 있습니다. 관련 데이터에 따르면, 60세 이상의 발병률은 12%에 달하며, 연령이 높아질수록 증가 추세에 있습니다.

퇴행성 무릎 관절염은 본질적으로 퇴행성 질환으로 임상적으로 완치할 수 없습니다. 현재 무릎 골관절염 환자들은 통증을 조절하고 삶의 질을 향상시키기 위해 물리치료, 진통제, 관절내 주사 등 보존적 치료를 주로 사용하고 있습니다. 약물 치료에 앞서 물리치료, 운동요법, 체중감량 등의 보조적인 치료법이 있습니다. 일반적으로 항염증 진통제는 무릎 관절염 치료의 1차 선택 약물로 알려져 있지만, 장기간 사용 시 부작용이 발생하는 경우가 많습니다. 관절 내 글루코코르티코이드나 히알루론산 나트륨 주사는 관절 내 염증을 완화하고 연골 회복을 촉진하는 것으로 알려져 있습니다. 반복 주사를 통해 효과를 유지할 수 있지만, 몇 년이 지나면 효과가 떨어집니다. 인공 슬관절 전치환술(TKA)이 유일한 최후의 수단으로 여겨지지만, 수술 후 효과가 불충분하거나 장기적인 수술 후 통증으로 고생하는 환자도 존재합니다. 무릎 관절염 환자의 통증 치료의 시급성으로 인해 무릎 신경 절제술 기술의 적용이 주목받고 있습니다.

무릎 신경 절제술에는 기존의 고주파 소작술(RFA), 펄스 고주파(PRF), 냉각 고주파 소작술(CRF), 레이저 치료 등이 있습니다. 무릎 신경차단술의 원리, 매개변수, 효과에 대해서는 아직 연구 초기 단계에 있으며, 연구팀에 따라 기술 방식에 큰 차이가 있습니다. 그러나 수많은 임상시험과 사례보고를 체계적으로 평가한 결과, 무릎 신경차단술은 무릎 관절염(KOA) 또는 슬관절 전치환술(TKA) 후 수술 후 통증 치료에 있어 최대 약 1년간 통증 완화 및 삶의 질 향상, 낮은 침습성, 적은 합병증 등의 장점이 있는 것으로 나타났습니다. 장점이 있는 것으로 제시되고 있습니다.

당사의 데이터에 따르면, 2024년 전 세계 무릎 신경 절제술 시행 건수는 약 13만 건이었으며, 2025년에는 15만 5천 건에 달할 것으로 예측됩니다. 향후 5년간 무릎 신경 절제술의 CAGR은 15% 이상에 달할 것으로 예상되며, 2030년까지 시장 규모는 1억 달러 이상에 달할 것으로 전망됩니다. 지역별로 보면, 북미는 의료시설의 확충과 첨단 기술로 인해 무릎 신경차단술 산업에서 주요 위치를 차지하고 있으며, 2024년 시장 점유율은 약 50%를 보일 것으로 예측됩니다. 그 다음이 유럽, 아시아태평양이 그 뒤를 잇습니다. 기술적으로는 무릎 신경 절제술의 주요 방법은 고주파 절제술로, 2024년에는 90% 이상을 차지했습니다. 그러나 레이저 치료(침습적 LA) 등의 방법도 점차 우위를 보이며 빠르게 발전하고 있습니다.

평균 수명이 연장됨에 따라 퇴행성 질환으로 인한 건강 문제는 필연적으로 주요 건강 위협이 될 수밖에 없습니다. 무릎관절은 인체의 중요한 하중 관절이며, 만성통증, 특히 무릎관절염(KOA)은 환자의 삶의 질을 현저하게 떨어뜨립니다. 중등도에서 중증의 난치성 무릎 관절염 환자는 기존 치료법으로는 효과가 제한적이며, 많은 부작용을 감수해야 합니다. 인공 슬관절 전치환술(TKA)은 일부 환자의 문제만 해결할 수 있으며, 수술 결과가 좋지 않거나 수술 적응증이 아닌 환자도 존재합니다. 통증 치료에서 무릎 신경 절제술은 좋은 치료 효과와 높은 안전성을 보이고 있으며, 향후 시장 잠재력이 매우 큽니다.

이 보고서는 무릎 신경 절제술 세계 시장에 대해 총 판매량, 매출, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이 보고서는 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 포함하여 판매량(단위) 및 매출액(백만 달러)으로 무릎 신경 절제술 시장 규모, 추정 및 예측을 제시했습니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 무릎 신경절단 관련 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.

시장 세분화

기업별

  • Boston Scientific
  • Stryker
  • Abbott
  • Avanos Medical(coolief)
  • Cosman Medical
  • Diros Technology
  • Vantage MedTech
  • STARmed America
  • Beijing Neo Science

유형별 부문

  • 표준 RFA
  • 냉각식 RFA
  • 기타

용도별 부문

  • 병원
  • 진료소

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 기타 중동 및 아프리카
LSH

자주 묻는 질문

  • 무릎 신경 절제술 시장 규모는 어떻게 예측되나요?
  • 2024년 전 세계 무릎 신경 절제술 시행 건수는 어떻게 되나요?
  • 무릎 신경 절제술의 주요 방법은 무엇인가요?
  • 무릎 신경 절제술 시장에서 북미의 점유율은 어떻게 되나요?
  • 무릎 신경 절제술의 장점은 무엇인가요?
  • 무릎 신경 절제술 시장의 주요 기업은 어디인가요?

The global market for Knee Denervation was estimated to be worth US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Knee Denervation cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Knee denervation is a minimally invasive medical procedure designed to reduce chronic knee pain, typically in patients with osteoarthritis or persistent pain following knee surgeries, such as knee replacements. The procedure involves selectively interrupting the sensory nerves that transmit pain signals from the knee to the brain. This is achieved without affecting motor function, thereby preserving joint movement.

Osteoarthritis (OA) is a degenerative disease common in synovial joints, which can cause degeneration of articular cartilage, bone hyperplasia at the joint margin and under the cartilage, etc. Knee osteoarthritis (KOA) is the most common knee disease in the limb joints. Domestic statistics show that more than 3% of people in my country suffer from OA, and KOA accounts for the majority. As my country gradually enters an aging society, the incidence of KOA is higher in the population. According to relevant data, the incidence rate in people over 60 years old is as high as 12%, and it is increasing with age.

KOA is essentially a degenerative disease and cannot be cured clinically. At present, KOA patients mostly use conservative treatments such as physical therapy, analgesics and intra-articular injections to control pain and improve their quality of life. Before drug intervention, there are auxiliary treatment measures such as physical therapy, exercise, and weight loss. It is generally believed that anti-inflammatory analgesics are the first choice for the treatment of KOA, but long-term use often produces adverse reactions. Intra-articular injection of glucocorticoids or sodium hyaluronate is believed to relieve inflammation in the joint and promote cartilage repair. Repeated injections can maintain the efficacy, but the effect will still decline after several years. Total knee arthroplasty (TKA) surgery is considered to be the only effective ultimate solution, but some patients still have poor postoperative effects or long-term postoperative pain. The urgent need for pain treatment in KOA patients has given rise to the application of Knee Denervation technology in this field.

Knee Denervation includes traditional radiofrequency ablation (RFA), pulsed radiofrequency (PRF), cooled RFA (CRF) and laser treatment. The principles, parameters and efficacy of Knee Denervation technology are still in the early stages, which leads to large differences in the technical methods used by different research teams. However, through a systematic evaluation of numerous clinical trials and case reports, it can still be concluded that Knee Denervation can relieve pain and improve quality of life for up to about 1 year in the treatment of postoperative pain after KOA or TKA, and has the advantages of less trauma and fewer complications.

According to our data, the global volume of Knee Denervation surgeries will be around 130,000 in 2024, and the volume is expected to reach 155,000 in 2025. The compound annual growth rate of Knee Denervation will reach more than 15% in the next five years, and the market size will exceed US$100 million by 2030. From a regional perspective, North America occupies a major position in the Knee Denervation industry with its complete medical facilities and advanced technology, with a market share of nearly 50% in 2024, followed by Europe and Asia Pacific. From a technical point of view, the main method of Knee Denervation is radiofrequency ablation, which will account for more than 90% in 2024, but laser therapy (invasive LA) and other methods are gradually showing their advantages and are developing rapidly.

With the extension of life expectancy, the health problems caused by degenerative diseases will inevitably become a major health threat. The knee joint is an important load-bearing joint in the human body. Chronic pain, especially KOA, will seriously reduce the quality of life of patients. Patients with moderate to severe or refractory KOA benefit less from traditional treatments and have to endure many adverse reactions. TKA surgery can only solve the problems of some patients. Some patients still have poor surgical results or do not have the conditions for surgical treatment. Knee Denervation for pain treatment has shown good therapeutic effects and high safety, and has huge market potential in the future.

This report aims to provide a comprehensive presentation of the global market for Knee Denervation, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Knee Denervation by region & country, by Type, and by Application.

The Knee Denervation market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Knee Denervation.

Market Segmentation

By Company

  • Boston Scientific
  • Stryker
  • Abbott
  • Avanos Medical (coolief)
  • Cosman Medical
  • Diros Technology
  • Vantage MedTech
  • STARmed America
  • Beijing Neo Science

Segment by Type

  • Standard RFA
  • Cooled RFA
  • Others

Segment by Application

  • Hospital
  • Clinic

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Knee Denervation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Knee Denervation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Knee Denervation in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Knee Denervation Product Introduction
  • 1.2 Global Knee Denervation Market Size Forecast
    • 1.2.1 Global Knee Denervation Sales Value (2020-2031)
    • 1.2.2 Global Knee Denervation Sales Volume (2020-2031)
    • 1.2.3 Global Knee Denervation Sales Price (2020-2031)
  • 1.3 Knee Denervation Market Trends & Drivers
    • 1.3.1 Knee Denervation Industry Trends
    • 1.3.2 Knee Denervation Market Drivers & Opportunity
    • 1.3.3 Knee Denervation Market Challenges
    • 1.3.4 Knee Denervation Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Knee Denervation Players Revenue Ranking (2024)
  • 2.2 Global Knee Denervation Revenue by Company (2020-2025)
  • 2.3 Global Knee Denervation Players Sales Volume Ranking (2024)
  • 2.4 Global Knee Denervation Sales Volume by Company Players (2020-2025)
  • 2.5 Global Knee Denervation Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Knee Denervation Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Knee Denervation Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Knee Denervation
  • 2.9 Knee Denervation Market Competitive Analysis
    • 2.9.1 Knee Denervation Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Knee Denervation Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Denervation as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Standard RFA
    • 3.1.2 Cooled RFA
    • 3.1.3 Others
  • 3.2 Global Knee Denervation Sales Value by Type
    • 3.2.1 Global Knee Denervation Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Knee Denervation Sales Value, by Type (2020-2031)
    • 3.2.3 Global Knee Denervation Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Knee Denervation Sales Volume by Type
    • 3.3.1 Global Knee Denervation Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Knee Denervation Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Knee Denervation Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Knee Denervation Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Clinic
  • 4.2 Global Knee Denervation Sales Value by Application
    • 4.2.1 Global Knee Denervation Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Knee Denervation Sales Value, by Application (2020-2031)
    • 4.2.3 Global Knee Denervation Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Knee Denervation Sales Volume by Application
    • 4.3.1 Global Knee Denervation Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Knee Denervation Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Knee Denervation Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Knee Denervation Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Knee Denervation Sales Value by Region
    • 5.1.1 Global Knee Denervation Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Knee Denervation Sales Value by Region (2020-2025)
    • 5.1.3 Global Knee Denervation Sales Value by Region (2026-2031)
    • 5.1.4 Global Knee Denervation Sales Value by Region (%), (2020-2031)
  • 5.2 Global Knee Denervation Sales Volume by Region
    • 5.2.1 Global Knee Denervation Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Knee Denervation Sales Volume by Region (2020-2025)
    • 5.2.3 Global Knee Denervation Sales Volume by Region (2026-2031)
    • 5.2.4 Global Knee Denervation Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Knee Denervation Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Knee Denervation Sales Value, 2020-2031
    • 5.4.2 North America Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Knee Denervation Sales Value, 2020-2031
    • 5.5.2 Europe Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Knee Denervation Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Knee Denervation Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Knee Denervation Sales Value, 2020-2031
    • 5.7.2 South America Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Knee Denervation Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Knee Denervation Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Knee Denervation Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Knee Denervation Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Knee Denervation Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Knee Denervation Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Knee Denervation Sales Value, 2020-2031
    • 6.3.2 United States Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Knee Denervation Sales Value, 2020-2031
    • 6.4.2 Europe Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Knee Denervation Sales Value, 2020-2031
    • 6.5.2 China Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Knee Denervation Sales Value, 2020-2031
    • 6.6.2 Japan Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Knee Denervation Sales Value, 2020-2031
    • 6.7.2 South Korea Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Knee Denervation Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Knee Denervation Sales Value, 2020-2031
    • 6.9.2 India Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Knee Denervation Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Boston Scientific
    • 7.1.1 Boston Scientific Company Information
    • 7.1.2 Boston Scientific Introduction and Business Overview
    • 7.1.3 Boston Scientific Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Boston Scientific Knee Denervation Product Offerings
    • 7.1.5 Boston Scientific Recent Development
  • 7.2 Stryker
    • 7.2.1 Stryker Company Information
    • 7.2.2 Stryker Introduction and Business Overview
    • 7.2.3 Stryker Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Stryker Knee Denervation Product Offerings
    • 7.2.5 Stryker Recent Development
  • 7.3 Abbott
    • 7.3.1 Abbott Company Information
    • 7.3.2 Abbott Introduction and Business Overview
    • 7.3.3 Abbott Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Abbott Knee Denervation Product Offerings
    • 7.3.5 Abbott Recent Development
  • 7.4 Avanos Medical (coolief)
    • 7.4.1 Avanos Medical (coolief) Company Information
    • 7.4.2 Avanos Medical (coolief) Introduction and Business Overview
    • 7.4.3 Avanos Medical (coolief) Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Avanos Medical (coolief) Knee Denervation Product Offerings
    • 7.4.5 Avanos Medical (coolief) Recent Development
  • 7.5 Cosman Medical
    • 7.5.1 Cosman Medical Company Information
    • 7.5.2 Cosman Medical Introduction and Business Overview
    • 7.5.3 Cosman Medical Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Cosman Medical Knee Denervation Product Offerings
    • 7.5.5 Cosman Medical Recent Development
  • 7.6 Diros Technology
    • 7.6.1 Diros Technology Company Information
    • 7.6.2 Diros Technology Introduction and Business Overview
    • 7.6.3 Diros Technology Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Diros Technology Knee Denervation Product Offerings
    • 7.6.5 Diros Technology Recent Development
  • 7.7 Vantage MedTech
    • 7.7.1 Vantage MedTech Company Information
    • 7.7.2 Vantage MedTech Introduction and Business Overview
    • 7.7.3 Vantage MedTech Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Vantage MedTech Knee Denervation Product Offerings
    • 7.7.5 Vantage MedTech Recent Development
  • 7.8 STARmed America
    • 7.8.1 STARmed America Company Information
    • 7.8.2 STARmed America Introduction and Business Overview
    • 7.8.3 STARmed America Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 STARmed America Knee Denervation Product Offerings
    • 7.8.5 STARmed America Recent Development
  • 7.9 Beijing Neo Science
    • 7.9.1 Beijing Neo Science Company Information
    • 7.9.2 Beijing Neo Science Introduction and Business Overview
    • 7.9.3 Beijing Neo Science Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Beijing Neo Science Knee Denervation Product Offerings
    • 7.9.5 Beijing Neo Science Recent Development

8 Industry Chain Analysis

  • 8.1 Knee Denervation Industrial Chain
  • 8.2 Knee Denervation Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Knee Denervation Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Knee Denervation Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제